You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ixazomib

Showing 26 - 50 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Urothelial Carcinoma, Transitional Cell Carcinoma, Unresectable Transitional Cell Carcinoma Trial in Houston

Active, not recruiting
  • Metastatic Urothelial Carcinoma
  • +2 more
  • Doxorubicin Hydrochloride
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Multiple Myeloma in Relapse, Refractory Multiple Myeloma Trial in Israel (ixazomib-pomalidomide-dexamethasone)

Recruiting
  • Multiple Myeloma in Relapse
  • Refractory Multiple Myeloma
  • Afula, Israel
  • +7 more
Jul 10, 2022

Plasma Cell Leukemia, Plasma Cell Myeloma, Plasmacytoma Trial in Rochester, Nashville (Dexamethasone, Ixazomib Citrate,

Active, not recruiting
Has Results
  • Plasma Cell Leukemia
  • +2 more
  • Rochester, Minnesota
  • +1 more
May 19, 2022

Myeloma, Multiple Trial in United States (Lenalidomide, Ixazomib, Daratumumab Injection)

Recruiting
  • Myeloma, Multiple
  • Bangor, Maine
  • +7 more
Mar 10, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Mantle Cell Lymphoma Trial in Atlanta (Ixazomib, Rituximab)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ixazomib
  • Rituximab
  • Atlanta, Georgia
  • +1 more
Oct 26, 2021

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Buffalo, East Hills, West Islip (biological, drug, other)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Abatacept
  • +3 more
  • Buffalo, New York
  • +2 more
Dec 22, 2022

AL Amyloidosis Trial in United States (Ixazomib, Dexamethasone)

Recruiting
  • AL Amyloidosis
  • Boston, Massachusetts
  • +7 more
Jan 21, 2022

Refractory Plasma Cell Myeloma, Recurrent Plasma Cell Myeloma Trial in United States (ixazomib citrate, dexamethasone,

Active, not recruiting
Has Results
  • Refractory Plasma Cell Myeloma
  • Recurrent Plasma Cell Myeloma
  • ixazomib citrate
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Mar 28, 2022

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Bortezomib, Carfilzomib)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Ixazomib
  • +4 more
  • Kamogawa, Chiba, Japan
  • +22 more
Jul 27, 2022

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

ALL, Childhood, Lymphoblastic Lymphoma, Childhood, Lymphoblastic Leukemia, Acute, Childhood Trial in Australia, United States

Recruiting
  • ALL, Childhood
  • +2 more
  • Ixazomib
  • +7 more
  • Los Angeles, California
  • +17 more
Aug 11, 2022

Multiple Myeloma Trial in Worldwide (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Helsinki, Finland
  • +25 more
Mar 14, 2022

Multiple Myeloma at First Relapse Trial in France (Ixazomib, Iberdomide, Dexamethasone Oral)

Recruiting
  • Multiple Myeloma at First Relapse
  • Ixazomib
  • +2 more
  • Annecy, France
  • +20 more
Dec 16, 2021

Relapsed Refractory Multiple Myeloma Trial in United States (Abemaciclib, dexamethasone, ixazomib, pomalidomide, Enasidenib,

Recruiting
  • Relapsed Refractory Multiple Myeloma
  • Abemaciclib, dexamethasone, ixazomib, pomalidomide
  • +7 more
  • Phoenix, Arizona
  • +16 more
Sep 9, 2021

Recurrent AL Amyloidosis, Refractory AL Amyloidosis Trial in Duarte, Boston, Columbus (Bone Marrow Aspiration and Biopsy,

Recruiting
  • Recurrent AL Amyloidosis
  • Refractory AL Amyloidosis
  • Biospecimen Collection
  • +9 more
  • Duarte, California
  • +10 more
Jan 19, 2023

Myeloid Hematologic Malignancy, Lymphoid Hematologic Malignancy Trial in New York (Ixazomib)

Completed
  • Myeloid Hematologic Malignancy
  • Lymphoid Hematologic Malignancy
  • Ixazomib
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Sep 3, 2021

Multiple Myeloma Trial in Little Rock (Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Ixazomib
  • Little Rock, Arkansas
    University of Arkansas for Medical Science
May 17, 2021

Progression Free Survival, Overall Survival, Maintenance Trial (Ixazomib DX/Lenalidomide DX)

Not yet recruiting
  • Progression Free Survival
  • +2 more
  • Ixazomib DX/Lenalidomide DX
  • (no location specified)
Jul 27, 2022

Multiple Myeloma Trial in United States (Allogeneic HSCT, Fludarabine, Melphalan)

Completed
Has Results
  • Multiple Myeloma
  • Allogeneic HSCT
  • +5 more
  • Birmingham, Alabama
  • +14 more
Jan 25, 2022

Newly Diagnosed Multiple Myeloma Trial in New York (Daratumumab, Bortezomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Dec 29, 2022

Multiple Myeloma Trial in Odense (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • Odense, Denmark
    Odense University Hospital
Nov 18, 2021

Glioblastoma Trial in Atlanta (Ixazomib)

Completed
Has Results
  • Glioblastoma
  • Ixazomib
  • Atlanta, Georgia
    Emory University/Winship Cancer Institute
Mar 2, 2021

Multiple Myeloma Trial in Beijing (Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone)

Recruiting
  • Multiple Myeloma
  • Drug: Ixazomib Drug:pomalidomide Drug:dexamethasone
  • Beijing, Beijing, China
    PekingUMCH
Aug 15, 2021

Real-World Use of Ixazomib Citrate in People With Multiple

Recruiting
  • Multiple Myeloma
  • No Intervention
  • Anyang, Korea, Republic of
  • +20 more
Jun 15, 2022